ViiV Supported Studies Programme
Our Mission
ViiV Healthcare (VH) is an independent, global specialist HIV company established in 2009, committed to delivering innovative options for the care and treatment of people living with HIV/AIDS. Our support of investigator-sponsored research (ISR) plays a valuable role in fulfilling this mission.
The Investigator Sponsored Research Programme
An ISR is a research effort where the sponsor is the investigator, healthcare institution, or medical network
external to VH, seeking our support to conduct the work.
There are three different ways VH can provide support:
Pure Substance Requests (PSR) are entirely designed and managed by an external Sponsor. VH can support in the form of supplying active pharmaceutical ingredient (API)/pure substance of VH product for HIV research purposes.
Investigator Sponsored Studies (ISS) are entirely designed and managed by an external Sponsor. VH can support in the
form of funding and/or VH products.
Supported Collaborative Studies (SCS) are conducted by an external Sponsor, with VH contributing to study design and
deliverables, in addition to provision of funds and/or VH products.
VH accepts study proposals from investigators in two ways:
Areas of Interest: A sponsor/investigator has an idea/concept for a study based on a posted "Area of Interest" and
has discussed it with a VH representative. They submit their proposal via the ViiV ISR Portal based on the
appropriate study class (PSR, ISS, SCS). Upon submission, the proposal progresses through the review process.
Note: Although VH are more likely to support studies aligned to our current "Areas of Interest" for ISRs, we are
interested in supporting studies that are innovative an contribute to scientific knowledge relating to a product,
HIV or advancing technology.
Response to Request for Proposals: VH posts RFPs on this portal that are active for a specific response period and
identify "Priority Areas of Interest." Sponsors/Investigators are encouraged to respond by submitting a proposal via
this portal. These proposals are reviewed according to a specific schedule outlined in the RFP.
Pure Substance Requests/Studies
ISS & SCS
Requests/Studies
All Safety Reporting must be conducted as per your study agreement. If you need to report a suspected side effect for a ViiV Healthcare medicine that is not part of your study, please click the following.
Report a side effect
To report a suspected side effect, please use the online reporting form below. This facility is provided under our service agreement with GlaxoSmithKline (GSK), so please choose ‘ViiV Healthcare medicines’ from the drop-down product list on the form. In North America, you can report a side effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET.